Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study

Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study

Abstract Background Treatment of acute myeloid leukemia (AML) in elderly patients remains a great challenge. In this prospective single arm study (ChiCTR-OPC-15006492), we evaluated the efficacy and safety of a novel consolidation therapy with low-dose decitabine (LD-DAC) priming with intermediate-d...

Full description

Bibliographic Details
Main Authors: Xiaoyang Li, Yuexin Dong, Ya Li, Ruibao Ren, Wen Wu, Hongming Zhu, Yunxiang Zhang, Jiong Hu, Junmin Li
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Cancer
Subjects:
Acute myeloid leukemia
Decitabine
Umbilical cord blood
Online Access:http://link.springer.com/article/10.1186/s12885-019-5975-8

Internet

http://link.springer.com/article/10.1186/s12885-019-5975-8

Similar Items